September, 2025
September 2025
M T W T F S S
1234567
891011121314
15161718192021
22232425262728
2930  
Rami Manochakian: FLAURA2 Trial Update on EGFR+ Advanced Lung Cancer
Jul 21, 2025, 15:04

Rami Manochakian: FLAURA2 Trial Update on EGFR+ Advanced Lung Cancer

Rami Manochakian, Vice President of the North American Neuroendocrine Tumor Society, shared a post on X:

“Hot Off the Press. Big News Press Release by AstraZeneca.

FLAURA2 trial of Osimertinib + Chemotherapy vs Osimertinib in 1st line Therapy for patients with EGFR+ advanced Lung Cancer (NSCLC) shows: Statistically Significant and Clinically Meaningful Improvement in Overall Survival.”

FLAURA2 Trial

More posts featuring Rami Manochakian.